Superworth

Amgen shares outstanding AMGN

Diluted shares outstanding, averaged over each quarter, from 1995.

Latest quarter, to Jun 30, 2026
544M
On a year earlier
+0.6%
more shares

Amgen had 544M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is 0.6% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY2025543M+0%
FY2024542M+0%
FY2023540M+0%
FY2022539M−5%
FY2021565M−3%
FY2020584M−2%
FY2019597M−7%
FY2018641M−12%
FY2017725M−2%
FY2016742M−3%
FY2015763M−1%
FY2014773M+1%
FY2013768M−2%
FY2012781M−9%
FY2011859M−9%

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY26544M+1%
Q1 FY26544M+1%
Q4 FY25543M+0%
Q3 FY25542M+0%
Q2 FY25541M+0%
Q1 FY25541M+1%
Q4 FY24542M+0%
Q3 FY24542M+1%
Q2 FY24541M+1%
Q1 FY24536M−0%
Q4 FY23540M+0%
Q3 FY23538M+0%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Amgen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.